SYNTHES GMBH OCCIPITAL-PL 4.5/5 MED W/50 F/R ø4 TI; ORTHOSIS, CERVICAL PEDICLE SCREW SPINAL FIXATION
|
Back to Search Results |
|
Catalog Number 04.615.601S |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Insufficient Information (4580)
|
Event Type
Injury
|
Event Description
|
Device report from synthes reports an event in japan as follows: it was reported that this was a oc2 fusion on an unknown date.About two months after surgery, it was identified that the rod in question might have slipped off the plate in question.The revision surgery is scheduled on dec.22, 2023.The cause is unknown.The surgeon commented that re-operation is scheduled including confirmation of set screw, due to the possible loosening of fusion of occipital plate and rod about 2 months after surgery.No further information is available.This report is for one (1) occipital-pl 4.5/5 med w/50 f/r ã¸4 ti.This is report 1 of 1 for complaint (b)(4).
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.H3, h6: the investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H3, h4, h6: product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device history review (dhr): part number: 04.615.601s lot number: 5931p97 manufacturing site: mezzovico release to warehouse date: 31 may 2023 expiration date: 01 may 2033 a manufacturing record evaluation was performed for the sterile finished lot number, and no non-conformances were identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.G1: manufacture site updated h4: manufacture date updated.
|
|
Search Alerts/Recalls
|
|
|